References
1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 51. March 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf. Accessed May 21, 2020.
2. Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020; 80: 388-393.
3. People Who Are at Higher Risk for Severe Illness | Coronavirus | COVID-19 | CDC. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html. Accessed May 21, 2020.
4. Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions | FDA. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/coronavirus-disease-2019-covid-19-frequently-asked-questions. Accessed May 21, 2020.
5. Becker RC. Covid‑19 treatment update: follow the scientific evidence. J Thromb Thrombolysis. 2020. [Epub ahead of print].
6. The hunt for an effective treatment for COVID-19 | Feature | Pharmaceutical Journal. https://www.pharmaceutical-journal.com/news-and-analysis/features/the-hunt-for-an-effective-treatment-for-covid-19/20207883.article?firstPass=false. Accessed May 21, 2020.
7. Solidarity clinical trial for COVID-19 treatments. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments. Accessed April 26, 2020.
8. Drug Interaction Concerns for COVID-19 Treatments | Clinical Drug Information. https://www.wolterskluwercdi.com/blog/drug-interaction-concerns-covid-19-treatments/. Accessed April 28, 2020.
9. Back D, Marzolini C, Hodge C, et al. COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interaction. Br J Clin Pharmacol. [Epub ahead of print].
10. Liverpool COVID-19 Interactions. https://www.covid19-druginteractions.org/. Accessed April 28, 2020.
11. Lexi-Interact Data Fields. http://webstore.lexi.com/Information/Product-Information/Lexi-Interact-Fields. Accessed May 14, 2020.
12. Farzanegan B, Alehashem M, Bastani M, Baniasadi S. Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital. J Clin Pharmacol. 2015; 55: 132-136.
13. Hassanzad M, Tashayoie Nejad S, Mahboobipour AA, Salem F, Baniasadi S. Potential drug-drug interactions in hospitalized pediatric patients with respiratory disorders: A retrospective review of clinically important interactions. Drug Metab Pers Ther. 2020: 35.
14. Croxtall JD, Perry CM. LopinavirRitonavir: A review of its use in the management of HIV-1 infection. Drugs. 2010; 70: 1885-1915.
15. Chu CM, Cheng VCC, Hung IFN, et al. Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax. 2004; 59: 252-256.
16. Chan JFW, Yao Y, Yeung ML, et al. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERSCoV infection in a nonhuman primate model of common marmoset. J Infect Dis. 2015; 212: 1904-1913.
17. Hung IF, Lung K, Tso EY, et al. Articles Triple combination of interferon beta-1b , lopinavir – ritonavir , and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label , randomised , phase 2 trial. Lancet. 2020; 6736: 1-10.
18. Lopinavir and Ritonavir - Atorvastatin. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
19. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020; 5: 428-430.
20. Lopinavir and Ritonavir - Rosuvastatin. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
21. Mah Ming JB, Gill MJ. Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. AIDS Patient Care STDS. 2003; 17: 207‐210.
22. De Kanter CT, Keuter M, Van Der Lee MJ, Koopmans PP, Burger DM. Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir. Antivir Ther. 2011; 16: 435-437.
23. Lopinavir and Ritonavir - Alprazolam. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
24. Jenh Hsu A, Carson KA, Yung R, Paul A. Severe prolonged sedation associated with coadministration of protease inhibitors and intravenous midazolam during bronchoscopy. Pharmacotherapy. 2012; 32: 538-545.
25. Lopinavir and Ritonavir - Midazolam. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
26. Backman ES, Triant VA, Ehrenfeld JM, et al. Safety of midazolam for sedation of HIV-positive patients undergoing colonoscopy. HIV Med. 2013; 14: 379-384.
27. Clerkin KJ, Fried JA, Raikhelkar J, et al. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation. 2020. [Epub ahead of print].
28. Lopinavir and Ritonavir - Diltiazem. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
29. Kirby BJ, Collier AC, Kharasch ED, Whittington D, Thummel KE, Unadkat JD. Complex drug interactions of the HIV protease inhibitors 3: Effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropion. Drug Metab Dispos. 2012; 40: 610-616.
30. Lopinavir and Ritonavir - Digoxin. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
31. Lopinavir and Ritonavir - Amiodarone. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
32. Hosseinpoor Z, Farzanegan B, Seyyedi SR, Rajabi M, Baniasadi S. Drug interactions and creatinine levels are associated with QTc prolongation in intensive care units: A prospective, observational study. Drug Metab Pers Ther. 2019; 34 :2-8.
33. Hydroxychloroquine - Azithromycin. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
34. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020. [Epub ahead of print].
35. Vranckx P, Valgimigli M, Heidbuchel H. The significance of drug-drug and drug-food interactions of oral anticoagulation. Arrhythmia Electrophysiol Rev. 2018; 7: 55-61.
36. Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug–drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ. 2007;177:347-351.
37. Coronavirus disease 2019 (COVID-19) - Diagnosis and treatment - Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/coronavirus/diagnosis-treatment/drc-20479976. Accessed May 21, 2020.
38. Amici C, Di Caro A, Ciucci A, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2006; 11: 1021-1030.
39. Lopinavir and Ritonavir - Salmeterol. Interactions. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed April 30 2020.
40. Flomax (tamsulosin) [prescribing information]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020579s026lbl.pdf. Accessed May 21, 2020.
Table 1 Demographic and clinical characteristics of the patients